Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Allowed claims cover major features of pumping mechanism in FDA-cleared MODD1 product SAN DIEGO, CA / ACCESSWIRE / September ...
Future Market Insights5d
Global Insulin Pumps Market Set to Soar with Projected Growth to USD 14.8 Billion by 2032
The global insulin pumps market, valued at USD 5.5 billion in 2022, is poised for remarkable growth, with an anticipated ...
medtechdive7d
Embecta gets FDA nod for insulin patch pump
“As we continue to advance toward our vision of a life unlimited by diabetes, our team has focused on developing a patch pump that could address some of the most significant obstacles to adopting pump ...
Drug Store News10d
Embecta announces FDA clearance of disposable patch pump for type 2 diabetes
The system includes a wearable, disposable patch pump that provides adjustable basal and bolus insulin for up to three days, depending on the needs of the user.
MedPage Today13d
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win
Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...
Insulet’s (PODD) Sales And Margins Surpassed Expectations
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” ...
Investing17d
Modular Medical gets FDA nod for diabetes patch pum
SAN DIEGO – Modular Medical, Inc. (NASDAQ:MODD) has received clearance from the U.S. Food and Drug Administration (FDA) to market its new MODD1 insulin patch pump in the United States, the company ...
MarketWatch17d
Modular Medical Shares Rise 27% on FDA Clearance for Insulin Pump
Modular Medical shares rose after hours as the company received Food and Drug Administration clearance for its MODD1 insulin pump. The stock was up 27%, to $2.49, surpassing the prior 52-week high ...